Metropolis Healthcare · NSE: METROPOLIS · BSE: 542650
Q2 FY24 results · Jul–Sep 2023
Metropolis Healthcare reported revenue from operations of ₹308.50 crore (up 2.7% from Q2 FY23) and net profit of ₹35.66 crore (down 11.9% from Q2 FY23) for Q2 FY24 (Jul–Sep 2023), on a consolidated basis.
| Item | Q2 FY24 | Q2 FY23 | YoY | Q1 FY24 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 308.50 | 300.35 | +2.7% | 277.09 | +11.3% |
| Other income | 1.22 | 4.34 | −71.9% | 3.05 | −60.1% |
| Total income | 309.72 | 304.68 | +1.7% | 280.14 | +10.6% |
| Profit before tax | 48.11 | 54.80 | −12.2% | 39.19 | +22.8% |
| Net profit for the period | 35.66 | 40.48 | −11.9% | 28.98 | +23.0% |
| Attributable to shareholders of the company | 35.45 | 40.33 | −12.1% | 28.80 | +23.1% |
| EPS, basic (₹) | 6.92 | 7.88 | −12.2% | 5.62 | +23.1% |
| Net margin (%) | 11.6 | 13.5 | 10.5 |
| Item | Q2 FY24 | Q2 FY23 | YoY | Q1 FY24 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 285.46 | 280.06 | +1.9% | 256.29 | +11.4% |
| Other income | 2.01 | 2.93 | −31.5% | 2.78 | −27.8% |
| Total income | 287.46 | 282.99 | +1.6% | 259.07 | +11.0% |
| Profit before tax | 42.49 | 50.67 | −16.1% | 35.23 | +20.6% |
| Net profit for the period | 31.28 | 37.82 | −17.3% | 26.13 | +19.7% |
| EPS, basic (₹) | 6.11 | 7.39 | −17.3% | 5.10 | +19.8% |
| Net margin (%) | 11.0 | 13.5 | 10.2 |
Consolidated
- Filed with BSE
- 07 Nov 2023, 12:42 IST
- Board meeting
- 04 Nov 2023
- Period
- 01 Jul 2023 to 30 Sep 2023
- Review status
- Unaudited
- Source
- XBRL filing on BSE
Standalone
- Filed with BSE
- 07 Nov 2023, 12:42 IST
- Board meeting
- 04 Nov 2023
- Period
- 01 Jul 2023 to 30 Sep 2023
- Review status
- Unaudited
- Source
- XBRL filing on BSE